Given this context, we hypothesize that changes in DNA methylation levels in the promoter region of the GRIN2B gene in patients with bipolar depression may lead to reduced expression of NMDAR receptor subunits and glutamatergic dysfunction, thereby affecting cognitive function. This evidence concerns the gene GRIN2B and bipolar disorder.